These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21464820)
1. Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages. Ma HM; Wu Z; Nakanishi H Lab Invest; 2011 Jun; 91(6):921-31. PubMed ID: 21464820 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. Wu Z; Ma HM; Kukita T; Nakanishi Y; Nakanishi H J Immunol; 2010 Mar; 184(6):3191-201. PubMed ID: 20176740 [TBL] [Abstract][Full Text] [Related]
3. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403 [TBL] [Abstract][Full Text] [Related]
4. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway. Li X; Peng F; Xie C; Wu W; Han X; Chen L Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236 [TBL] [Abstract][Full Text] [Related]
5. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production. Lee SY; Lee KS; Yi SH; Kook SH; Lee JC PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641 [TBL] [Abstract][Full Text] [Related]
6. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834 [TBL] [Abstract][Full Text] [Related]
7. Effects of RGD-grafted phosphatidylserine-containing liposomes on the polarization of macrophages and bone tissue regeneration. Wu L; Kim Y; Seon GM; Choi SH; Park HC; Son G; Kim SM; Lim BS; Yang HC Biomaterials; 2021 Dec; 279():121239. PubMed ID: 34753037 [TBL] [Abstract][Full Text] [Related]
8. Involvement of p38 MAP Kinase in the inhibitory effects of phosphatidylserine liposomes on nitric oxide production from macrophages stimulated with LPS. Aramaki Y; Matsuno R; Tsuchiya S Biochem Biophys Res Commun; 2001 Feb; 280(4):982-7. PubMed ID: 11162622 [TBL] [Abstract][Full Text] [Related]
9. Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia. Zhang J; Fujii S; Wu Z; Hashioka S; Tanaka Y; Shiratsuchi A; Nakanishi Y; Nakanishi H J Neuroimmunol; 2006 Mar; 172(1-2):112-20. PubMed ID: 16371234 [TBL] [Abstract][Full Text] [Related]
10. Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages. Choe JY; Kim SK Int J Mol Med; 2017 Mar; 39(3):539-548. PubMed ID: 28204822 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358 [TBL] [Abstract][Full Text] [Related]
13. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE Lee WS; Shin JS; Jang DS; Lee KT Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413 [TBL] [Abstract][Full Text] [Related]
14. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623 [TBL] [Abstract][Full Text] [Related]
15. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages. Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747 [TBL] [Abstract][Full Text] [Related]
16. Tibetan medicine Kuan-Jin-Teng exerts anti-arthritic effects on collagen-induced arthritis rats via inhibition the production of pro-inflammatory cytokines and down-regulation of MAPK signaling pathway. Xiong H; Ding X; Wang H; Jiang H; Wu X; Tu C; Wu C; Pi Y; Yang G; Zhao Z; Mei Z Phytomedicine; 2019 Apr; 57():271-281. PubMed ID: 30802713 [TBL] [Abstract][Full Text] [Related]
17. FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways. Zhang N; Liu Z; Luo H; Wu W; Nie K; Cai L; Tan S; Chen X; Huang Y; Liu J; Lv M; Zhang X; Fan Y; Lin Y; Ye S; Liu Y; Wu L; Xu J Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431516 [TBL] [Abstract][Full Text] [Related]
18. Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. Lee B; Kim TH; Jun JB; Yoo DH; Woo JH; Choi SJ; Lee YH; Song GG; Sohn J; Park-Min KH; Ivashkiv LB; Ji JD J Immunol; 2010 Nov; 185(10):5926-34. PubMed ID: 20935210 [TBL] [Abstract][Full Text] [Related]
19. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism underlying anti-inflammatory activities of lirioresinol B dimethyl ether through suppression of NF-κB and MAPK signaling in in vitro and in vivo models. Su Y; Xiong S; Lan H; Xu L; Wei X Int Immunopharmacol; 2019 Aug; 73():321-332. PubMed ID: 31129419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]